N80.A49
Superficial endometriosis of unspecified ureter
Clinical Classification Guidelines
Medical Intelligence & Overview
Superficial endometriosis of the ureter is a condition where tissue similar to the lining of the uterus (endometrial tissue) abnormally grows on the outer surface of the ureter, the tube responsible for carrying urine from the kidneys to the bladder. This specific form, classified under ICD-10 code N80.A49, is considered superficial because the growths are limited to the surface layer without infiltrating deeper tissues. Although not as invasive as other forms, superficial endometriosis can lead to discomfort and complications if untreated, affecting urinary function and overall pelvic health.
Causes & Symptoms
Clinical Causes: Hormonal influences, particularly estrogen, which promote the growth of endometrial tissue outside the uterus. Genetic predisposition, with family history increasing risk. Developmental factors where misplaced endometrial cells implant during reproductive years. Immune system irregularities that fail to clear or control endometrial tissue growth. Previous pelvic or abdominal surgeries that may facilitate the dissemination of endometrial cells to abnormal locations.
Key Symptoms: Pelvic or lower abdominal pain, particularly during menstruation or urination. Dysuria, or pain during urination. Hematuria, which is visible blood in the urine, especially during menstrual periods. Frequent urinary tract infections or persistent urinary discomfort. Bfeelings of pressure or fullness in the pelvic area. Rarely, impaired kidney function if the ureter becomes significantly obstructed.
Diagnostic & Treatment
Diagnosis Path: Diagnosing superficial endometriosis of the ureter involves a combination of medical history, clinical examination, and specific diagnostic tests. Imaging techniques such as ultrasound, magnetic resonance imaging (MRI), or computed tomography (CT) scans can detect abnormalities or irregularities in the ureter. Additionally, cystoscopy—a procedure that allows visual inspection inside the bladder and ureter openings—might be performed. Definitive diagnosis often requires a surgical procedure called laparoscopy, where a small camera is inserted into the pelvic cavity to directly observe endometrial growths on the ureter's surface, sometimes followed by biopsy to confirm the nature of the tissue.
Treatment Protocols: Management of superficial endometriosis of the ureter aims to alleviate symptoms and preserve urinary function. Treatment options include: - **Medications**: Hormonal therapies such as birth control pills, GnRH agonists, or progestins to reduce estrogen levels and suppress endometrial tissue growth. - **Surgical intervention**: Laparoscopic removal of endometrial implants and possibly ureteral reconstruction if necessary to prevent obstruction or damage. - **Ureteral stenting**: In cases of significant narrowing or obstruction, stents may be placed to ensure urine flow. - **Postoperative care**: Regular follow-up to monitor for recurrence or complications. The choice of treatment depends on the severity of symptoms, extent of the disease, and the patient's reproductive plans.
Clinical Advice & FAQs
Billing Guidance
Is N80.A49 a billable ICD-10 code?
Yes, N80.A49 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N80.A49?
Clinical documentation must specify the nature of Superficial endometriosis of unspecified ureter and any associated comorbidities for accurate reporting.
Cite this Clinical Reference